Report Cover

Global Piroxicam Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Piroxicam market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Piroxicam size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Piroxicam market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Piroxicam market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Suppositories
    Injection
    Capsule
    Patch
    Other

Market segment by Application, can be divided into
    Tendonitis
    Systemic Traumatic Pain
    Musculoskeletal Pain
    Contraception
    Rheumatoid Arthritis
    Chronic Infectious Arthritis
    Osteoarthritis
    Other

Market segment by players, this report covers
    Pfizer
    Teva
    Mylan
    Nostrum
    DCPC
    FANGMING
    JINGHUA
    JUMPCAN
    Technilab Pharma
    Apotex Corporation
    Keltman Pharmaceuticals
    Genpharm
    Bayer
    PLX Pharma
    Chiesi
    SK Chemicals
    Bioglan Laboratories
    APR
    CJ HealthCare
    SkyePharma
    Changzhou Siyao Pharmaceutical
    Shanxi Yunpeng Pharmaceutical

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of Piroxicam
    1.2 Classification of Piroxicam by Type
        1.2.1 Overview: Global Piroxicam Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Piroxicam Revenue Market Share by Type in 2020
        1.2.3 Suppositories
        1.2.4 Injection
        1.2.5 Capsule
        1.2.6 Patch
        1.2.7 Other
    1.3 Global Piroxicam Market by Application
        1.3.1 Overview: Global Piroxicam Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Tendonitis
        1.3.3 Systemic Traumatic Pain
        1.3.4 Musculoskeletal Pain
        1.3.5 Contraception
        1.3.6 Rheumatoid Arthritis
        1.3.7 Chronic Infectious Arthritis
        1.3.8 Osteoarthritis
        1.3.9 Other
    1.4 Global Piroxicam Market Size & Forecast
    1.5 Global Piroxicam Market Size and Forecast by Region
        1.5.1 Global Piroxicam Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Piroxicam Market Size by Region, (2016-2021)
        1.5.3 North America Piroxicam Market Size and Prospect (2016-2026)
        1.5.4 Europe Piroxicam Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Piroxicam Market Size and Prospect (2016-2026)
        1.5.6 South America Piroxicam Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Piroxicam Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Piroxicam Market Drivers
        1.6.2 Piroxicam Market Restraints
        1.6.3 Piroxicam Trends Analysis
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Piroxicam Product and Solutions
        2.1.4 Pfizer Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Teva
        2.2.1 Teva Details
        2.2.2 Teva Major Business
        2.2.3 Teva Piroxicam Product and Solutions
        2.2.4 Teva Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Teva Recent Developments and Future Plans
    2.3 Mylan
        2.3.1 Mylan Details
        2.3.2 Mylan Major Business
        2.3.3 Mylan Piroxicam Product and Solutions
        2.3.4 Mylan Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Mylan Recent Developments and Future Plans
    2.4 Nostrum
        2.4.1 Nostrum Details
        2.4.2 Nostrum Major Business
        2.4.3 Nostrum Piroxicam Product and Solutions
        2.4.4 Nostrum Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Nostrum Recent Developments and Future Plans
    2.5 DCPC
        2.5.1 DCPC Details
        2.5.2 DCPC Major Business
        2.5.3 DCPC Piroxicam Product and Solutions
        2.5.4 DCPC Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 DCPC Recent Developments and Future Plans
    2.6 FANGMING
        2.6.1 FANGMING Details
        2.6.2 FANGMING Major Business
        2.6.3 FANGMING Piroxicam Product and Solutions
        2.6.4 FANGMING Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 FANGMING Recent Developments and Future Plans
    2.7 JINGHUA
        2.7.1 JINGHUA Details
        2.7.2 JINGHUA Major Business
        2.7.3 JINGHUA Piroxicam Product and Solutions
        2.7.4 JINGHUA Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 JINGHUA Recent Developments and Future Plans
    2.8 JUMPCAN
        2.8.1 JUMPCAN Details
        2.8.2 JUMPCAN Major Business
        2.8.3 JUMPCAN Piroxicam Product and Solutions
        2.8.4 JUMPCAN Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 JUMPCAN Recent Developments and Future Plans
    2.9 Technilab Pharma
        2.9.1 Technilab Pharma Details
        2.9.2 Technilab Pharma Major Business
        2.9.3 Technilab Pharma Piroxicam Product and Solutions
        2.9.4 Technilab Pharma Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Technilab Pharma Recent Developments and Future Plans
    2.10 Apotex Corporation 
        2.10.1 Apotex Corporation Details
        2.10.2 Apotex Corporation Major Business
        2.10.3 Apotex Corporation Piroxicam Product and Solutions
        2.10.4 Apotex Corporation Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Apotex Corporation Recent Developments and Future Plans
    2.11 Keltman Pharmaceuticals
        2.11.1 Keltman Pharmaceuticals Details
        2.11.2 Keltman Pharmaceuticals Major Business
        2.11.3 Keltman Pharmaceuticals Piroxicam Product and Solutions
        2.11.4 Keltman Pharmaceuticals Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Keltman Pharmaceuticals Recent Developments and Future Plans
    2.12 Genpharm
        2.12.1 Genpharm Details
        2.12.2 Genpharm Major Business
        2.12.3 Genpharm Piroxicam Product and Solutions
        2.12.4 Genpharm Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Genpharm Recent Developments and Future Plans
    2.13 Bayer
        2.13.1 Bayer Details
        2.13.2 Bayer Major Business
        2.13.3 Bayer Piroxicam Product and Solutions
        2.13.4 Bayer Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Bayer Recent Developments and Future Plans
    2.14 PLX Pharma
        2.14.1 PLX Pharma Details
        2.14.2 PLX Pharma Major Business
        2.14.3 PLX Pharma Piroxicam Product and Solutions
        2.14.4 PLX Pharma Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 PLX Pharma Recent Developments and Future Plans
    2.15 Chiesi
        2.15.1 Chiesi Details
        2.15.2 Chiesi Major Business
        2.15.3 Chiesi Piroxicam Product and Solutions
        2.15.4 Chiesi Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Chiesi Recent Developments and Future Plans
    2.16 SK Chemicals
        2.16.1 SK Chemicals Details
        2.16.2 SK Chemicals Major Business
        2.16.3 SK Chemicals Piroxicam Product and Solutions
        2.16.4 SK Chemicals Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 SK Chemicals Recent Developments and Future Plans
    2.17 Bioglan Laboratories
        2.17.1 Bioglan Laboratories Details
        2.17.2 Bioglan Laboratories Major Business
        2.17.3 Bioglan Laboratories Piroxicam Product and Solutions
        2.17.4 Bioglan Laboratories Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Bioglan Laboratories Recent Developments and Future Plans
    2.18 APR
        2.18.1 APR Details
        2.18.2 APR Major Business
        2.18.3 APR Piroxicam Product and Solutions
        2.18.4 APR Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 APR Recent Developments and Future Plans
    2.19 CJ HealthCare
        2.19.1 CJ HealthCare Details
        2.19.2 CJ HealthCare Major Business
        2.19.3 CJ HealthCare Piroxicam Product and Solutions
        2.19.4 CJ HealthCare Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 CJ HealthCare Recent Developments and Future Plans
    2.20 SkyePharma
        2.20.1 SkyePharma Details
        2.20.2 SkyePharma Major Business
        2.20.3 SkyePharma Piroxicam Product and Solutions
        2.20.4 SkyePharma Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 SkyePharma Recent Developments and Future Plans
    2.21 Changzhou Siyao Pharmaceutical
        2.21.1 Changzhou Siyao Pharmaceutical Details
        2.21.2 Changzhou Siyao Pharmaceutical Major Business
        2.21.3 Changzhou Siyao Pharmaceutical Piroxicam Product and Solutions
        2.21.4 Changzhou Siyao Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 Changzhou Siyao Pharmaceutical Recent Developments and Future Plans
    2.22 Shanxi Yunpeng Pharmaceutical
        2.22.1 Shanxi Yunpeng Pharmaceutical Details
        2.22.2 Shanxi Yunpeng Pharmaceutical Major Business
        2.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Product and Solutions
        2.22.4 Shanxi Yunpeng Pharmaceutical Piroxicam Revenue, Gross Margin and Market Share (2019-2021)
        2.22.5 Shanxi Yunpeng Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Piroxicam Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Piroxicam Players Market Share
        3.2.2 Top 10 Piroxicam Players Market Share
        3.2.3 Market Competition Trend
    3.3 Piroxicam Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Piroxicam Revenue and Market Share by Type (2016-2021)
    4.2 Global Piroxicam Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Piroxicam Revenue Market Share by Application (2016-2021)
    5.2 Piroxicam Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Piroxicam Revenue by Type (2016-2026)
    6.2 North America Piroxicam Revenue by Application (2016-2026)
    6.3 North America Piroxicam Market Size by Country
        6.3.1 North America Piroxicam Revenue by Country (2016-2026)
        6.3.2 United States Piroxicam Market Size and Forecast (2016-2026)
        6.3.3 Canada Piroxicam Market Size and Forecast (2016-2026)
        6.3.4 Mexico Piroxicam Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Piroxicam Revenue by Type (2016-2026)
    7.2 Europe Piroxicam Revenue by Application (2016-2026)
    7.3 Europe Piroxicam Market Size by Country
        7.3.1 Europe Piroxicam Revenue by Country (2016-2026)
        7.3.2 Germany Piroxicam Market Size and Forecast (2016-2026)
        7.3.3 France Piroxicam Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Piroxicam Market Size and Forecast (2016-2026)
        7.3.5 Russia Piroxicam Market Size and Forecast (2016-2026)
        7.3.6 Italy Piroxicam Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Piroxicam Revenue by Type (2016-2026)
    8.2 Asia-Pacific Piroxicam Revenue by Application (2016-2026)
    8.3 Asia-Pacific Piroxicam Market Size by Region
        8.3.1 Asia-Pacific Piroxicam Revenue by Region (2016-2026)
        8.3.2 China Piroxicam Market Size and Forecast (2016-2026)
        8.3.3 Japan Piroxicam Market Size and Forecast (2016-2026)
        8.3.4 South Korea Piroxicam Market Size and Forecast (2016-2026)
        8.3.5 India Piroxicam Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Piroxicam Market Size and Forecast (2016-2026)
        8.3.7 Australia Piroxicam Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Piroxicam Revenue by Type (2016-2026)
    9.2 South America Piroxicam Revenue by Application (2016-2026)
    9.3 South America Piroxicam Market Size by Country
        9.3.1 South America Piroxicam Revenue by Country (2016-2026)
        9.3.2 Brazil Piroxicam Market Size and Forecast (2016-2026)
        9.3.3 Argentina Piroxicam Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Piroxicam Revenue by Type (2016-2026)
    10.2 Middle East & Africa Piroxicam Revenue by Application (2016-2026)
    10.3 Middle East & Africa Piroxicam Market Size by Country
        10.3.1 Middle East & Africa Piroxicam Revenue by Country (2016-2026)
        10.3.2 Turkey Piroxicam Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Piroxicam Market Size and Forecast (2016-2026)
        10.3.4 UAE Piroxicam Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Piroxicam Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Piroxicam Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Piroxicam Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Piroxicam Revenue (USD Million) by Region (2016-2021) Table 5. Global Piroxicam Revenue Market Share by Region (2021-2026) Table 6. Pfizer Corporate Information, Head Office, and Major Competitors Table 7. Pfizer Major Business Table 8. Pfizer Piroxicam Product and Solutions Table 9. Pfizer Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Teva Corporate Information, Head Office, and Major Competitors Table 11. Teva Major Business Table 12. Teva Piroxicam Product and Solutions Table 13. Teva Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Mylan Corporate Information, Head Office, and Major Competitors Table 15. Mylan Major Business Table 16. Mylan Piroxicam Product and Solutions Table 17. Mylan Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Nostrum Corporate Information, Head Office, and Major Competitors Table 19. Nostrum Major Business Table 20. Nostrum Piroxicam Product and Solutions Table 21. Nostrum Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. DCPC Corporate Information, Head Office, and Major Competitors Table 23. DCPC Major Business Table 24. DCPC Piroxicam Product and Solutions Table 25. DCPC Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. FANGMING Corporate Information, Head Office, and Major Competitors Table 27. FANGMING Major Business Table 28. FANGMING Piroxicam Product and Solutions Table 29. FANGMING Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. JINGHUA Corporate Information, Head Office, and Major Competitors Table 31. JINGHUA Major Business Table 32. JINGHUA Piroxicam Product and Solutions Table 33. JINGHUA Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. JUMPCAN Corporate Information, Head Office, and Major Competitors Table 35. JUMPCAN Major Business Table 36. JUMPCAN Piroxicam Product and Solutions Table 37. JUMPCAN Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Technilab Pharma Corporate Information, Head Office, and Major Competitors Table 39. Technilab Pharma Major Business Table 40. Technilab Pharma Piroxicam Product and Solutions Table 41. Technilab Pharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Apotex Corporation Corporate Information, Head Office, and Major Competitors Table 43. Apotex Corporation Major Business Table 44. Apotex Corporation Piroxicam Product and Solutions Table 45. Apotex Corporation Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Keltman Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 47. Keltman Pharmaceuticals Major Business Table 48. Keltman Pharmaceuticals Piroxicam Product and Solutions Table 49. Keltman Pharmaceuticals Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Genpharm Corporate Information, Head Office, and Major Competitors Table 51. Genpharm Major Business Table 52. Genpharm Piroxicam Product and Solutions Table 53. Genpharm Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Bayer Corporate Information, Head Office, and Major Competitors Table 55. Bayer Major Business Table 56. Bayer Piroxicam Product and Solutions Table 57. Bayer Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. PLX Pharma Corporate Information, Head Office, and Major Competitors Table 59. PLX Pharma Major Business Table 60. PLX Pharma Piroxicam Product and Solutions Table 61. PLX Pharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Chiesi Corporate Information, Head Office, and Major Competitors Table 63. Chiesi Major Business Table 64. Chiesi Piroxicam Product and Solutions Table 65. Chiesi Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. SK Chemicals Corporate Information, Head Office, and Major Competitors Table 67. SK Chemicals Major Business Table 68. SK Chemicals Piroxicam Product and Solutions Table 69. SK Chemicals Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Bioglan Laboratories Corporate Information, Head Office, and Major Competitors Table 71. Bioglan Laboratories Major Business Table 72. Bioglan Laboratories Piroxicam Product and Solutions Table 73. Bioglan Laboratories Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. APR Corporate Information, Head Office, and Major Competitors Table 75. APR Major Business Table 76. APR Piroxicam Product and Solutions Table 77. APR Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. CJ HealthCare Corporate Information, Head Office, and Major Competitors Table 79. CJ HealthCare Major Business Table 80. CJ HealthCare Piroxicam Product and Solutions Table 81. CJ HealthCare Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 82. SkyePharma Corporate Information, Head Office, and Major Competitors Table 83. SkyePharma Major Business Table 84. SkyePharma Piroxicam Product and Solutions Table 85. SkyePharma Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 86. Changzhou Siyao Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 87. Changzhou Siyao Pharmaceutical Major Business Table 88. Changzhou Siyao Pharmaceutical Piroxicam Product and Solutions Table 89. Changzhou Siyao Pharmaceutical Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 90. Shanxi Yunpeng Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 91. Shanxi Yunpeng Pharmaceutical Major Business Table 92. Shanxi Yunpeng Pharmaceutical Piroxicam Product and Solutions Table 93. Shanxi Yunpeng Pharmaceutical Piroxicam Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 94. Global Piroxicam Revenue (USD Million) by Players (2019-2021) Table 95. Global Piroxicam Revenue Share by Players (2019-2021) Table 96. Breakdown of Piroxicam by Company Type (Tier 1, Tier 2 and Tier 3) Table 97. Piroxicam Players Head Office, Products and Services Provided Table 98. Piroxicam Mergers & Acquisitions in the Past Five Years Table 99. Piroxicam New Entrants and Expansion Plans Table 100. Global Piroxicam Revenue (USD Million) by Type (2016-2021) Table 101. Global Piroxicam Revenue Share by Type (2016-2021) Table 102. Global Piroxicam Revenue Forecast by Type (2021-2026) Table 103. Global Piroxicam Revenue by Application (2016-2021) Table 104. Global Piroxicam Revenue Forecast by Application (2021-2026) Table 105. North America Piroxicam Revenue by Type (2016-2021) & (USD Million) Table 106. North America Piroxicam Revenue by Type (2021-2026) & (USD Million) Table 107. North America Piroxicam Revenue by Application (2016-2021) & (USD Million) Table 108. North America Piroxicam Revenue by Application (2021-2026) & (USD Million) Table 109. North America Piroxicam Revenue by Country (2016-2021) & (USD Million) Table 110. North America Piroxicam Revenue by Country (2021-2026) & (USD Million) Table 111. Europe Piroxicam Revenue by Type (2016-2021) & (USD Million) Table 112. Europe Piroxicam Revenue by Type (2021-2026) & (USD Million) Table 113. Europe Piroxicam Revenue by Application (2016-2021) & (USD Million) Table 114. Europe Piroxicam Revenue by Application (2021-2026) & (USD Million) Table 115. Europe Piroxicam Revenue by Country (2016-2021) & (USD Million) Table 116. Europe Piroxicam Revenue by Country (2021-2026) & (USD Million) Table 117. Asia-Pacific Piroxicam Revenue by Type (2016-2021) & (USD Million) Table 118. Asia-Pacific Piroxicam Revenue by Type (2021-2026) & (USD Million) Table 119. Asia-Pacific Piroxicam Revenue by Application (2016-2021) & (USD Million) Table 120. Asia-Pacific Piroxicam Revenue by Application (2021-2026) & (USD Million) Table 121. Asia-Pacific Piroxicam Revenue by Region (2016-2021) & (USD Million) Table 122. Asia-Pacific Piroxicam Revenue by Region (2021-2026) & (USD Million) Table 123. South America Piroxicam Revenue by Type (2016-2021) & (USD Million) Table 124. South America Piroxicam Revenue by Type (2021-2026) & (USD Million) Table 125. South America Piroxicam Revenue by Application (2016-2021) & (USD Million) Table 126. South America Piroxicam Revenue by Application (2021-2026) & (USD Million) Table 127. South America Piroxicam Revenue by Country (2016-2021) & (USD Million) Table 128. South America Piroxicam Revenue by Country (2021-2026) & (USD Million) Table 129. Middle East & Africa Piroxicam Revenue by Type (2016-2021) & (USD Million) Table 130. Middle East & Africa Piroxicam Revenue by Type (2021-2026) & (USD Million) Table 131. Middle East & Africa Piroxicam Revenue by Application (2016-2021) & (USD Million) Table 132. Middle East & Africa Piroxicam Revenue by Application (2021-2026) & (USD Million) Table 133. Middle East & Africa Piroxicam Revenue by Country (2016-2021) & (USD Million) Table 134. Middle East & Africa Piroxicam Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Piroxicam Picture Figure 2. Global Piroxicam Revenue Market Share by Type in 2020 Figure 3. Suppositories Figure 4. Injection Figure 5. Capsule Figure 6. Patch Figure 7. Other Figure 8. Piroxicam Revenue Market Share by Application in 2020 Figure 9. Tendonitis Picture Figure 10. Systemic Traumatic Pain Picture Figure 11. Musculoskeletal Pain Picture Figure 12. Contraception Picture Figure 13. Rheumatoid Arthritis Picture Figure 14. Chronic Infectious Arthritis Picture Figure 15. Osteoarthritis Picture Figure 16. Other Picture Figure 17. Global Piroxicam Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 18. Global Piroxicam Revenue and Forecast (2016-2026) & (USD Million) Figure 19. Global Piroxicam Revenue Market Share by Region (2016-2026) Figure 20. Global Piroxicam Revenue Market Share by Region in 2020 Figure 21. North America Piroxicam Revenue (USD Million) and Growth Rate (2016-2026) Figure 22. Europe Piroxicam Revenue (USD Million) and Growth Rate (2016-2026) Figure 23. Asia-Pacific Piroxicam Revenue (USD Million) and Growth Rate (2016-2026) Figure 24. South America Piroxicam Revenue (USD Million) and Growth Rate (2016-2026) Figure 25. Middle East and Africa Piroxicam Revenue (USD Million) and Growth Rate (2016-2026) Figure 26. Piroxicam Market Drivers Figure 27. Piroxicam Market Restraints Figure 28. Piroxicam Market Trends Figure 29. Pfizer Recent Developments and Future Plans Figure 30. Teva Recent Developments and Future Plans Figure 31. Mylan Recent Developments and Future Plans Figure 32. Nostrum Recent Developments and Future Plans Figure 33. DCPC Recent Developments and Future Plans Figure 34. FANGMING Recent Developments and Future Plans Figure 35. JINGHUA Recent Developments and Future Plans Figure 36. JUMPCAN Recent Developments and Future Plans Figure 37. Technilab Pharma Recent Developments and Future Plans Figure 38. Apotex Corporation Recent Developments and Future Plans Figure 39. Keltman Pharmaceuticals Recent Developments and Future Plans Figure 40. Genpharm Recent Developments and Future Plans Figure 41. Bayer Recent Developments and Future Plans Figure 42. PLX Pharma Recent Developments and Future Plans Figure 43. Chiesi Recent Developments and Future Plans Figure 44. SK Chemicals Recent Developments and Future Plans Figure 45. Bioglan Laboratories Recent Developments and Future Plans Figure 46. APR Recent Developments and Future Plans Figure 47. CJ HealthCare Recent Developments and Future Plans Figure 48. SkyePharma Recent Developments and Future Plans Figure 49. Changzhou Siyao Pharmaceutical Recent Developments and Future Plans Figure 50. Shanxi Yunpeng Pharmaceutical Recent Developments and Future Plans Figure 51. Global Piroxicam Revenue Share by Players in 2020 Figure 52. Piroxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 53. Global Top 3 Players Piroxicam Revenue Market Share in 2020 Figure 54. Global Top 10 Players Piroxicam Revenue Market Share in 2020 Figure 55. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 56. Global Piroxicam Revenue Share by Type in 2020 Figure 57. Global Piroxicam Market Share Forecast by Type (2021-2026) Figure 58. Global Piroxicam Revenue Share by Application in 2020 Figure 59. Global Piroxicam Market Share Forecast by Application (2021-2026) Figure 60. North America Piroxicam Sales Market Share by Type (2016-2026) Figure 61. North America Piroxicam Sales Market Share by Application (2016-2026) Figure 62. North America Piroxicam Revenue Market Share by Country (2016-2026) Figure 63. United States Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Canada Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Mexico Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Europe Piroxicam Sales Market Share by Type (2016-2026) Figure 67. Europe Piroxicam Sales Market Share by Application (2016-2026) Figure 68. Europe Piroxicam Revenue Market Share by Country (2016-2026) Figure 69. Germany Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. France Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. United Kingdom Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Russia Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Italy Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Asia-Pacific Piroxicam Sales Market Share by Type (2016-2026) Figure 75. Asia-Pacific Piroxicam Sales Market Share by Application (2016-2026) Figure 76. Asia-Pacific Piroxicam Revenue Market Share by Region (2016-2026) Figure 77. China Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Japan Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. South Korea Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. India Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 81. Southeast Asia Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 82. Australia Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 83. South America Piroxicam Sales Market Share by Type (2016-2026) Figure 84. South America Piroxicam Sales Market Share by Application (2016-2026) Figure 85. South America Piroxicam Revenue Market Share by Country (2016-2026) Figure 86. Brazil Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 87. Argentina Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 88. Middle East and Africa Piroxicam Sales Market Share by Type (2016-2026) Figure 89. Middle East and Africa Piroxicam Sales Market Share by Application (2016-2026) Figure 90. Middle East and Africa Piroxicam Revenue Market Share by Country (2016-2026) Figure 91. Turkey Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 92. Saudi Arabia Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 93. UAE Piroxicam Revenue and Growth Rate (2016-2026) & (USD Million) Figure 94. Methodology Figure 95. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us